Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/05 → 6/30/07 |
A Phase II Study to Determine the Activity of BMS-354825 in Subjects with Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Disease that is Resistant to High Dose Imatinib Meslyate (Gleevec) or Who are Intolerant of Imatinib
- Brown, Randy (PI)